Letters
Adjuvant trastuzumab for breast cancer: Editorial does not mention health economics of drug
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1203 (Published 17 November 2005) Cite this as: BMJ 2005;331:1203
- E Hamish McLaren (handsmclaren@btinternet.com), retired consultant physician
- Badmany House, Beith, Ayrshire KA15 2JL
EDITOR—Why does the BMJ, which promotes itself as a journal dedicated to evidence based medicine, publish an editorial that talks only of the hazard ratio of a treatment without any reference to the absolute reduction in recurrence observed? …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.